SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-026737
Filing Date
2014-04-09
Accepted
2014-04-09 16:38:29
Documents
6
Period of Report
2014-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-10244_18k.htm 8-K 30872
2 EX-1.1 a14-10244_1ex1d1.htm EX-1.1 295180
3 EX-5.1 a14-10244_1ex5d1.htm EX-5.1 8237
4 EX-99.1 a14-10244_1ex99d1.htm EX-99.1 7075
5 GRAPHIC g102441mmi001.jpg GRAPHIC 2973
6 GRAPHIC g102441kii001.jpg GRAPHIC 6628
  Complete submission text file 0001104659-14-026737.txt   356235
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 14753877
SIC: 2834 Pharmaceutical Preparations